MENU
TBXU
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

TBXU stock forecast, quote, news & analysis

The investment seeks daily investment results, before fees and expenses, of 200% of the daily performance of the NYSE Biotechnology Index... Show more

Category: #Trading
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for TBXU with price predictions
Nov 06, 2026

Momentum Indicator for TBXU turns positive, indicating new upward trend

TBXU saw its Momentum Indicator move above the 0 level on October 15, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 13 similar instances where the indicator turned positive. In 12 of the 13 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for TBXU just turned positive on October 15, 2026. Looking at past instances where TBXU's MACD turned positive, the stock continued to rise in 8 of 9 cases over the following month. The odds of a continued upward trend are 89%.

TBXU moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TBXU crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 2 of 2 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +8.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where TBXU advanced for three days, in 41 of 46 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.

The Aroon Indicator entered an Uptrend today. In 48 of 56 cases where TBXU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.

Bearish Trend Analysis

The 10-day RSI Indicator for TBXU moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 12 similar instances where the indicator moved out of overbought territory. In 10 of the 12 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

TBXU broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks daily investment results, before fees and expenses, of 200% of the daily performance of the NYSE Biotechnology Index. The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments, such as swap agreements, securities of the index, and exchange-traded funds ("ETFs") that track the index, that, in combination, provide 2X daily leveraged exposure to the index, consistent with the fund's investment objective. The components of the index and the percentages represented by various sectors in the index may change over time. The fund is non-diversified.

Market Cap

The average market capitalization across the Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) ETF is 149.13B. The market cap for tickers in the group ranges from 58.01B to 248.92B. AMGN holds the highest valuation in this group at 248.92B. The lowest valued company is ARGX at 58.01B.

High and low price notable news

The average weekly price growth across all stocks in the Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) ETF was 10%. For the same ETF, the average monthly price growth was 23%, and the average quarterly price growth was 40%. ARGX experienced the highest price growth at 4%, while REGN experienced the biggest fall at -3%.

Volume

The average weekly volume growth across all stocks in the Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) ETF was -51%. For the same stocks of the ETF, the average monthly volume growth was 26% and the average quarterly volume growth was -60%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 76
P/E Growth Rating: 46
Price Growth Rating: 18
SMR Rating: 50
Profit Risk Rating: 19
Seasonality Score: 20 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Leveraged Equity
Address
Direxion Shares ETF Trust33 Whitehall Street,10th FloorNew York
Phone
866-476-7523
Web
http://www.direxioninvestments.com/
Momentum Indicator for TBXU turns positive, indicating new upward trend